We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
-14.85%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$637M
AUM Growth
-$214M
Cap. Flow
-$70.8M
Cap. Flow %
-11.11%
Top 10 Hldgs %
18.21%
Holding
581
New
183
Increased
73
Reduced
207
Closed
105

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$14.4M
2
NFLX icon
Netflix
NFLX
+$9.91M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$8M
4
TDOC icon
Teladoc Health
TDOC
+$7.16M
5
CIEN icon
Ciena
CIEN
+$6.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.1M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10M
3
BIIB icon
Biogen
BIIB
+$8.82M
4
BABA icon
Alibaba
BABA
+$8.42M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.33M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Healthcare 20.95%
3 Industrials 11.87%
4 Financials 8.28%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBR
76
DELISTED
CyberArk
CYBR
$2.33M 0.37%
31,429
+5,966
+23% +$426K
HCI icon
77
HCI Group
HCI
$2.28B
$2.3M 0.36%
45,197
-2,893
-6% -$142K
COUP
78
DELISTED
Coupa Software Incorporated
COUP
$2.29M 0.36%
36,372
+31,898
+713% +$2.02M
COWN
79
DELISTED
Cowen Inc. Class A Common Stock
COWN
$2.28M 0.36%
170,649
-9,522
-5% -$145K
MRSH
80
Marsh
MRSH
$90.1B
$2.26M 0.35%
28,345
-277
-1% -$23.1K
HWKN icon
81
Hawkins
HWKN
$2.7B
$2.25M 0.35%
109,924
-3,676
-3% -$71.5K
OXFD
82
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.23M 0.35%
174,499
+3,482
+2% +$52.8K
SBBP
83
DELISTED
Strongbridge Biopharma plc.
SBBP
$2.21M 0.35%
494,375
+60,214
+14% +$294K
GOOG icon
84
Alphabet (Google) Class C
GOOG
$4.19T
$2.17M 0.34%
41,840
-187,080
-82% -$10M
VZ icon
85
Verizon
VZ
$195B
$2.16M 0.34%
38,352
-974
-2% -$55.3K
PG icon
86
Procter & Gamble
PG
$335B
$2.14M 0.34%
23,284
-264
-1% -$23.6K
KGC icon
87
Kinross Gold
KGC
$32.6B
$2.1M 0.33%
649,308
+331,542
+104% +$928K
AZN icon
88
AstraZeneca
AZN
$246B
$2.1M 0.33%
27,681
-196
-0.7% -$15.3K
CUTR
89
DELISTED
Cutera, Inc.
CUTR
$2.1M 0.33%
123,071
+3,858
+3% +$78.7K
GLDD
90
DELISTED
Great Lakes Dredge & Dock
GLDD
$2.06M 0.32%
311,264
-14,329
-4% -$93.4K
NEM icon
91
Newmont
NEM
$124B
$2.05M 0.32%
59,190
+14,293
+32% +$463K
CGNX icon
92
Cognex
CGNX
$10.2B
$2.05M 0.32%
52,938
+33,001
+166% +$1.43M
INVE icon
93
Identive
INVE
$63.4M
$2.02M 0.32%
560,315
-32,345
-5% -$173K
VKTX icon
94
Viking Therapeutics
VKTX
$3.97B
$2.01M 0.32%
+263,105
New +$3.15M
STRL icon
95
Sterling Infrastructure
STRL
$16.8B
$2M 0.31%
183,890
-12,249
-6% -$149K
VMC icon
96
Vulcan Materials
VMC
$36.3B
$1.98M 0.31%
20,042
+11,768
+142% +$1.19M
APC
97
DELISTED
Anadarko Petroleum
APC
$1.97M 0.31%
44,998
-51,959
-54% -$2.93M
MLM icon
98
Martin Marietta Materials
MLM
$32.7B
$1.95M 0.31%
11,333
+6,669
+143% +$1.18M
BNFT
99
DELISTED
Benefitfocus, Inc.
BNFT
$1.91M 0.3%
41,798
-2,562
-6% -$107K
WPM icon
100
Wheaton Precious Metals
WPM
$61.3B
$1.91M 0.3%
97,633
+61,843
+173% +$1.05M

Similar funds

Essex Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Essex Investment Management held 581 positions worth $637M, down 25% from $851M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Essex Investment Management withdrew a net $70.8M in Q4 2018, closing 105 positions and reducing 207 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $5.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in NVIDIA worth $10.1M.

  • Essex Investment Management's largest Q4 2018 buy was NVIDIA: 3,018,520 shares worth $10.1M.
  • Essex Investment Management added most to VanEck Junior Gold Miners ETF in Q4 2018, an estimated $8M increase.
  • Essex Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $10.1M.
  • Essex Investment Management fully exited Regeneron Pharmaceuticals in Q4 2018, selling an estimated $5.1M.
  • Essex Investment Management's ten largest holdings make up 18% of its $637M portfolio in Q4 2018.
  • Essex Investment Management opened 183 new positions and closed 105 in Q4 2018.
  • Essex Investment Management's portfolio value fell 25% quarter-over-quarter to $637M.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.